ASXL1 and B-cell chronic lymphocytic leukemia: Further analysis of the RNA-seq data from mice that received tertiary transplantation and developed advanced CLL confirmed that ERV expression was indeed specifically upregulated in Asxl1/Ezh2 dKO as compared with the control WT CD19+ B cells or TCL1 CD19+ CLL cells (Figure 3L).